Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

utomilumab 1 infigratinib 1 human papillomavirus vaccine, L1 type 16, 18 1 fludarabine 1 durvalumab 1 Interleukin-2 1 Immunoglobulin G 1 Engerix-B 1 Disulfides 1 Data Collection 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Papillomavirus Infections × Engerix-B × Clear all

NCT01082861 2010-03-19

TANGO

National Institute for Public Health and the Environment (RIVM)

Phase 4 Terminated

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡